Contact Me - QA VALIDATION ENGINEER CONSULTANT (UK)

+44 79 19 49 39 39 wilsonblaney@gmail.com

Home
LinkedIn Profile
- CV
- Clients
Contact Me
cGMP Reference Guides
Validation Protocols
Validation Books
Blog
- Privacy Policy
- Copyright

Select Page

MHRA Drug Safety Alerts

Carbimazole: increased risk of congenital malformations; strengthened advice on contraception February 20, 2019
Carbimazole: risk of acute pancreatitis February 20, 2019

MHRA Recall Notices

Drug Alert Class 4: Paracetamol Infusion, Accord. (MDR 07-02/19) February 28, 2019
Class 4 defect information: Atropine Sulfate 3mg/10ml Solution for injection in pre-filled syringe. (MDR 18-01/19) February 18, 2019

FDA Recall Notices

Mylan Institutional LLC Initiates Voluntary Nationwide Recall of Levoleucovorin Injection Due to the Presence of Particulate Matter March 18, 2019
Legacy Pharmaceutical Packaging, LLC Issues Voluntary Nationwide Recall of Losartan Potassium Tablets, USP, 50mg Due to the Detection of Trace Amounts of N-Nitroso N-Methyl 4-amino butyric acid (NMBA) Impurity found in the Active Pharmaceutical Ingredient (API) March 16, 2019

Categories

EudraLex
FDA Latest News
MHRA News
Novartis
Pharmaceutical Validation Blog
Process Validation Engineer

Recent Posts

Doctors pounce on ‘alarmist,’ ‘horrifying’ Novartis heart-failure ad February 23, 2016
Latest Novartis News February 18, 2016

Home
LinkedIn Profile
Contact Me
cGMP Reference Guides
Validation Protocols
Validation Books
Blog

Designed by Elegant Themes | Powered by WordPress